Sarcopenic Obesity: Epidemiology, Pathophysiology, Cardiovascular Disease, Mortality, and Management

Overview

Journal Front Endocrinol (Lausanne)

Specialty Endocrinology

Date 2023 Jul 17

PMID 37455897

Authors

Shibo Wei

Thanh T Nguyen

Yan Zhang

Dongryeol Ryu

Karim Gariani

Affiliations

Soon will be listed here.

Abstract

Sarcopenic obesity is defined as the coexistence of sarcopenia and obesity in the same individual, characterized by of the co-presence of body fat accumulation and muscle loss. This condition is currently a major concern as it is associated with frailty and disabilities such as cardiovascular disease, fractures, dementia, cancer, and increased all-cause mortality. Particularly, older individuals remain at risk of sarcopenic obesity. Progress at several levels is needed to improve the global prognostic outlook for this condition, including the elaboration and implementation of a more uniform definition that may favor the identification and specification of prevalence by age group. Furthermore, improvements in the understanding of the pathogenesis of sarcopenic obesity may lead to the development of more specific therapeutic interventions to improve prognosis. We reviewed the knowledge on sarcopenic obesity and its associations with cardiovascular diseases and mortality.

Citing Articles

Special Diets and Nutrient Intakes in Morbidly Obese US Adults in Comparison to the 2020-2025 Dietary Guidelines for Americans.

Storz M, Stubing F, Huber R Nutr J. 2025; 24(1):37.

PMID: 40057715 PMC: 11889755. DOI: 10.1186/s12937-025-01088-7.

Effect of adipose-related parameters on mortality in patients with liver cirrhosis: a meta-analysis.

Wen Z, Tuo S, Ran Q, Yuan J, Li Y, Zhang Y Ann Med. 2025; 57(1):2473627.

PMID: 40038873 PMC: 11884100. DOI: 10.1080/07853890.2025.2473627.

Sarcopenia and Cardiogeriatrics: The Links Between Skeletal Muscle Decline and Cardiovascular Aging.

Anagnostou D, Theodorakis N, Hitas C, Kreouzi M, Pantos I, Vamvakou G Nutrients. 2025; 17(2).

PMID: 39861412 PMC: 11767851. DOI: 10.3390/nu17020282.

Effects of Hot Water Extract and Oregonin on Muscle Loss and Muscle Atrophy in C2C12 Murine Skeletal Muscle Cells.

An D, Lee C, Kwon Y, Kim T, Kim E, Jung J Pharmaceuticals (Basel). 2025; 17(12.

PMID: 39770504 PMC: 11676106. DOI: 10.3390/ph17121661.

Bridging the Gap: Supplements Strategies from Experimental Research to Clinical Applications in Sarcopenic Obesity.

Virgolici B, Dobre M, Stefan D Curr Issues Mol Biol. 2024; 46(12):13418-13430.

PMID: 39727928 PMC: 11726983. DOI: 10.3390/cimb46120800.

References

Lach-Trifilieff E, Minetti G, Sheppard K, Ibebunjo C, Feige J, Hartmann S . An antibody blocking activin type II receptors induces strong skeletal muscle hypertrophy and protects from atrophy. Mol Cell Biol. 2013; 34(4):606-18. PMC: 3911487. DOI: 10.1128/MCB.01307-13. View

Jung H, Park J, Kim D, Jang I, Park S, Lee J . Association between serum FGF21 level and sarcopenia in older adults. Bone. 2021; 145:115877. DOI: 10.1016/j.bone.2021.115877. View

Shin M, Jeon Y, Kim I . Testosterone and Sarcopenia. World J Mens Health. 2018; 36(3):192-198. PMC: 6119844. DOI: 10.5534/wjmh.180001. View

Yoo J, Park S, Jun J, Jin S, Hur K, Lee M . Relationship between low skeletal muscle mass, sarcopenic obesity and left ventricular diastolic dysfunction in Korean adults. Diabetes Metab Res Rev. 2020; 37(1):e3363. DOI: 10.1002/dmrr.3363. View

Lee K . Sarcopenic obesity and 10-year cardiovascular disease risk scores in cancer survivors and non-cancer participants using a nationwide survey. Eur J Cancer Care (Engl). 2020; 30(2):e13365. DOI: 10.1111/ecc.13365. View

Zhang X, Xie X, Dou Q, Liu C, Zhang W, Yang Y . Association of sarcopenic obesity with the risk of all-cause mortality among adults over a broad range of different settings: a updated meta-analysis. BMC Geriatr. 2019; 19(1):183. PMC: 6610788. DOI: 10.1186/s12877-019-1195-y. View

Landi F, Marzetti E, Martone A, Bernabei R, Onder G . Exercise as a remedy for sarcopenia. Curr Opin Clin Nutr Metab Care. 2013; 17(1):25-31. DOI: 10.1097/MCO.0000000000000018. View

Asrih M, Wei S, Nguyen T, Yi H, Ryu D, Gariani K . Overview of growth differentiation factor 15 in metabolic syndrome. J Cell Mol Med. 2023; 27(9):1157-1167. PMC: 10148061. DOI: 10.1111/jcmm.17725. View

dos Santos E, Gadelha A, Safons M, Nobrega O, Oliveira R, Lima R . Sarcopenia and sarcopenic obesity classifications and cardiometabolic risks in older women. Arch Gerontol Geriatr. 2014; 59(1):56-61. DOI: 10.1016/j.archger.2014.03.012. View

10.

Kim T, Yang S, Yoo H, Lim K, Kang H, Song W . Prevalence of sarcopenia and sarcopenic obesity in Korean adults: the Korean sarcopenic obesity study. Int J Obes (Lond). 2009; 33(8):885-92. DOI: 10.1038/ijo.2009.130. View

11.

Stensvold D, Viken H, Steinshamn S, Dalen H, Stoylen A, Loennechen J . Effect of exercise training for five years on all cause mortality in older adults-the Generation 100 study: randomised controlled trial. BMJ. 2020; 371:m3485. PMC: 7539760. DOI: 10.1136/bmj.m3485. View

12.

Hotamisligil G . Endoplasmic reticulum stress and the inflammatory basis of metabolic disease. Cell. 2010; 140(6):900-17. PMC: 2887297. DOI: 10.1016/j.cell.2010.02.034. View

13.

Gao Q, Mei F, Shang Y, Hu K, Chen F, Zhao L . Global prevalence of sarcopenic obesity in older adults: A systematic review and meta-analysis. Clin Nutr. 2021; 40(7):4633-4641. DOI: 10.1016/j.clnu.2021.06.009. View

14.

Sato R, Okada K, Akiyama E, Konishi M, Matsuzawa Y, Nakahashi H . Impact of sarcopenic obesity on long-term clinical outcomes after ST-segment elevation myocardial infarction. Atherosclerosis. 2021; 335:135-141. DOI: 10.1016/j.atherosclerosis.2021.08.038. View

15.

Mitchell W, Williams J, Atherton P, Larvin M, Lund J, Narici M . Sarcopenia, dynapenia, and the impact of advancing age on human skeletal muscle size and strength; a quantitative review. Front Physiol. 2012; 3:260. PMC: 3429036. DOI: 10.3389/fphys.2012.00260. View

16.

Dickinson J, Fry C, Drummond M, Gundermann D, Walker D, Glynn E . Mammalian target of rapamycin complex 1 activation is required for the stimulation of human skeletal muscle protein synthesis by essential amino acids. J Nutr. 2011; 141(5):856-62. PMC: 3077888. DOI: 10.3945/jn.111.139485. View

17.

Ma J, Hwang S, McMahon G, Curhan G, McLean R, Murabito J . Mid-adulthood cardiometabolic risk factor profiles of sarcopenic obesity. Obesity (Silver Spring). 2016; 24(2):526-34. DOI: 10.1002/oby.21356. View

18.

Villareal D, Aguirre L, Gurney A, Waters D, Sinacore D, Colombo E . Aerobic or Resistance Exercise, or Both, in Dieting Obese Older Adults. N Engl J Med. 2017; 376(20):1943-1955. PMC: 5552187. DOI: 10.1056/NEJMoa1616338. View

19.

Atkins J, Whincup P, Morris R, Lennon L, Papacosta O, Wannamethee S . Sarcopenic obesity and risk of cardiovascular disease and mortality: a population-based cohort study of older men. J Am Geriatr Soc. 2014; 62(2):253-60. PMC: 4234002. DOI: 10.1111/jgs.12652. View

20.

Goisser S, Kemmler W, Porzel S, Volkert D, Sieber C, Bollheimer L . Sarcopenic obesity and complex interventions with nutrition and exercise in community-dwelling older persons--a narrative review. Clin Interv Aging. 2015; 10:1267-82. PMC: 4531044. DOI: 10.2147/CIA.S82454. View